217 related articles for article (PubMed ID: 26477873)
1. Prospective Surveillance of Extreme Neonatal Hyperbilirubinemia in Australia.
McGillivray A; Polverino J; Badawi N; Evans N
J Pediatr; 2016 Jan; 168():82-87.e3. PubMed ID: 26477873
[TBL] [Abstract][Full Text] [Related]
2. Extreme neonatal hyperbilirubinemia and kernicterus spectrum disorder in Denmark during the years 2000-2015.
Donneborg ML; Hansen BM; Vandborg PK; Rodrigo-Domingo M; Ebbesen F
J Perinatol; 2020 Feb; 40(2):194-202. PubMed ID: 31907395
[TBL] [Abstract][Full Text] [Related]
3. Incidence and causes of severe neonatal hyperbilirubinemia in Canada.
Sgro M; Campbell D; Shah V
CMAJ; 2006 Sep; 175(6):587-90. PubMed ID: 16966660
[TBL] [Abstract][Full Text] [Related]
4. Severe Neonatal Hyperbilirubinemia Decreased after the 2007 Canadian Guidelines.
Sgro M; Kandasamy S; Shah V; Ofner M; Campbell D
J Pediatr; 2016 Apr; 171():43-7. PubMed ID: 26852177
[TBL] [Abstract][Full Text] [Related]
5. Rates of Extreme Neonatal Hyperbilirubinemia and Kernicterus in Children and Adherence to National Guidelines for Screening, Diagnosis, and Treatment in Sweden.
Alkén J; Håkansson S; Ekéus C; Gustafson P; Norman M
JAMA Netw Open; 2019 Mar; 2(3):e190858. PubMed ID: 30901042
[TBL] [Abstract][Full Text] [Related]
6. The Preterm Infant: A High-Risk Situation for Neonatal Hyperbilirubinemia Due to Glucose-6-Phosphate Dehydrogenase Deficiency.
Kaplan M; Hammerman C; Bhutani VK
Clin Perinatol; 2016 Jun; 43(2):325-40. PubMed ID: 27235211
[TBL] [Abstract][Full Text] [Related]
7. Universal bilirubin screening for severe neonatal hyperbilirubinemia.
Bhutani VK; Vilms RJ; Hamerman-Johnson L
J Perinatol; 2010 Oct; 30 Suppl():S6-15. PubMed ID: 20877410
[TBL] [Abstract][Full Text] [Related]
8. Prospective cohort study of neurodevelopmental outcomes following extreme neonatal hyperbilirubinaemia in Australia.
McGillivray AJ; Polverino J; Badawi N; Evans NJ
J Paediatr Child Health; 2023 Nov; 59(11):1244-1250. PubMed ID: 37724614
[TBL] [Abstract][Full Text] [Related]
9. Management of neonatal hyperbilirubinemia: pediatricians' practices and educational needs.
Petrova A; Mehta R; Birchwood G; Ostfeld B; Hegyi T
BMC Pediatr; 2006 Mar; 6():6. PubMed ID: 16519797
[TBL] [Abstract][Full Text] [Related]
10. Exchange transfusion in infants with extreme hyperbilirubinemia: an experience from a developing country.
Salas AA; Mazzi E
Acta Paediatr; 2008 Jun; 97(6):754-8. PubMed ID: 18422806
[TBL] [Abstract][Full Text] [Related]
11. Neonatal hyperbilirubinemia and bilirubin neurotoxicity in hospitalized neonates: analysis of the US Database.
Qattea I; Farghaly MAA; Elgendy M; Mohamed MA; Aly H
Pediatr Res; 2022 Jun; 91(7):1662-1668. PubMed ID: 34429513
[TBL] [Abstract][Full Text] [Related]
12. Outcomes in a population of healthy term and near-term infants with serum bilirubin levels of >or=325 micromol/L (>or=19 mg/dL) who were born in Nova Scotia, Canada, between 1994 and 2000.
Jangaard KA; Fell DB; Dodds L; Allen AC
Pediatrics; 2008 Jul; 122(1):119-24. PubMed ID: 18595994
[TBL] [Abstract][Full Text] [Related]
13. ABO hemolytic disease of the fetus and newborn: thirteen years of data after implementing a universal bilirubin screening and management program.
Christensen RD; Baer VL; MacQueen BC; O'Brien EA; Ilstrup SJ
J Perinatol; 2018 May; 38(5):517-525. PubMed ID: 29410540
[TBL] [Abstract][Full Text] [Related]
14. Extreme neonatal hyperbilirubinemia, acute bilirubin encephalopathy, and kernicterus spectrum disorder in children with galactosemia.
Bech LF; Donneborg ML; Lund AM; Ebbesen F
Pediatr Res; 2018 Aug; 84(2):228-232. PubMed ID: 29892033
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for neurotoxicity in newborns with severe neonatal hyperbilirubinemia.
Gamaleldin R; Iskander I; Seoud I; Aboraya H; Aravkin A; Sampson PD; Wennberg RP
Pediatrics; 2011 Oct; 128(4):e925-31. PubMed ID: 21911352
[TBL] [Abstract][Full Text] [Related]
16. Systematic review of screening for bilirubin encephalopathy in neonates.
Trikalinos TA; Chung M; Lau J; Ip S
Pediatrics; 2009 Oct; 124(4):1162-71. PubMed ID: 19786450
[TBL] [Abstract][Full Text] [Related]
17. Incidence of chronic bilirubin encephalopathy in Canada, 2007-2008.
Sgro M; Campbell DM; Kandasamy S; Shah V
Pediatrics; 2012 Oct; 130(4):e886-90. PubMed ID: 22966025
[TBL] [Abstract][Full Text] [Related]
18. Clinical report from the pilot USA Kernicterus Registry (1992 to 2004).
Johnson L; Bhutani VK; Karp K; Sivieri EM; Shapiro SM
J Perinatol; 2009 Feb; 29 Suppl 1():S25-45. PubMed ID: 19177057
[TBL] [Abstract][Full Text] [Related]
19. [Clinical characteristics of bilirubin encephalopathy in Chinese newborn infants-a national multicenter survey].
;
Zhonghua Er Ke Za Zhi; 2012 May; 50(5):331-5. PubMed ID: 22883033
[TBL] [Abstract][Full Text] [Related]
20. Exchange Transfusion Trends and Risk Factors for Extreme Neonatal Hyperbilirubinemia over 10 Years in Shiraz, Iran.
Hemmati F; Mahini SM; Bushehri M; Asadi AH; Barzegar H
Iran J Med Sci; 2024 Jun; 49(6):384-393. PubMed ID: 38952637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
